NRF2 knockdown had a pronounced effect on gene expression in MDA-MB-436 breast cancer cells, notably reducing multiple anti-ferroptosis genes, including SLC7A11, NQO1, TXNRD1, GCLM, and AKR1C1. This evidence concerns the gene NFE2L2 and breast cancer.